High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
1 clinical trials · Condition
◉ Watch High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
| Record | Firm | Date |
|---|---|---|
| Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma (NCT06649812) | National Cancer Institute (NCI) | 2025-10-07 |
Track High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements automatically
Every clearance here is in the API, with alerts when new ones post.